We are live on ! Find out more
INKT icon

MiNK Therapeutics
INKT

25 hedge funds and large institutions have $1.71M invested in MiNK Therapeutics in 2025 Q4 according to their latest regulatory filings, with 7 funds opening new positions, 3 increasing their positions, 6 reducing their positions, and 0 closing their positions.

New
Increased
Maintained
Reduced
Closed

39% more funds holding

Funds holding: 18 → 25 (+7)

34% more capital invested

Capital invested by funds: $1.28M → $1.71M (+$429K)

1.24% more ownership

Funds ownership: 2.02% → 3.26% (+1.2%)

50% less repeat investments, than reductions

Existing positions increased: 3 | Existing positions reduced: 6

Holders
25
Holders Change
+7
Holders Change %
+38.89%
% of All Funds
0.3%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
7
Increased
3
Reduced
6
Closed
–
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$443K
2
DS
DRW Securities
Illinois
+$332K
3
UBS Group
UBS Group
Switzerland
+$50.4K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$18.6K
5
Citigroup
Citigroup
New York
+$4.35K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$54.2K
2
TRCT
Tower Research Capital (TRC)
New York
-$8.15K
3
BlackRock
BlackRock
New York
-$1.23K
4
Morgan Stanley
Morgan Stanley
New York
-$142
5
Osaic Holdings
Osaic Holdings
Arizona
-$90
Name Holding Trade Value Shares
Change 		Change in
Stake
Vanguard Group
1
Vanguard Group
Pennsylvania
$754K +$443K +34,300 +103%
DS
2
DRW Securities
Illinois
$286K +$332K +25,677 New
LF
3
Longbow Finance
Switzerland
$186K – – –
Geode Capital Management
4
Geode Capital Management
Massachusetts
$159K +$18.6K +1,441 +11%
Renaissance Technologies
5
Renaissance Technologies
New York
$116K -$54.2K -4,200 -29%
UBS Group
6
UBS Group
Switzerland
$106K +$50.4K +3,900 +69%
BlackRock
7
BlackRock
New York
$69.2K -$1.23K -95 -2%
PP
8
Paladin Partners
Wisconsin
$11.2K +$12.9K +1,000 New
Bank of America
9
Bank of America
North Carolina
$6.33K – – –
Citigroup
10
Citigroup
New York
$3.76K +$4.35K +337 New
TRCT
11
Tower Research Capital (TRC)
New York
$3.29K -$8.15K -631 -68%
HFS
12
Horizon Financial Services
North Carolina
$1.78K +$2.07K +160 New
Osaic Holdings
13
Osaic Holdings
Arizona
$1.3K -$90 -7 -6%
Morgan Stanley
14
Morgan Stanley
New York
$1.16K -$142 -11 -10%
C
15
Covestor
United Kingdom
$1K – – –
Wells Fargo
16
Wells Fargo
California
$223 +$258 +20 New
Northwestern Mutual Wealth Management
17
Northwestern Mutual Wealth Management
Wisconsin
$201 -$13 -1 -5%
BNP Paribas Financial Markets
18
BNP Paribas Financial Markets
France
$178 – – –
GPFA
19
Game Plan Financial Advisors
Ohio
$178 – – –
CA
20
Clearstead Advisors
Ohio
$157 – – –
JP Morgan Chase
21
JP Morgan Chase
New York
$100 – – –
PWPS
22
Pinnacle Wealth Planning Services
Ohio
$56 +$65 +5 New
KFI
23
Key Financial Inc
Pennsylvania
$45 – – –
Barclays
24
Barclays
United Kingdom
$45 +$52 +4 New
Jones Financial Companies
25
Jones Financial Companies
Missouri
$11 – – –

INKT Hedge Fund Activity: Q4 2025 in Review

25 of the 8,228 institutional investors tracked by Wall St. Rank reported a position in MiNK Therapeutics (INKT) for Q4 2025, worth a combined $1.71M — up 34% from $1.28M a quarter earlier.

Buyers outnumbered sellers: 7 funds opened new INKT positions and 0 closed out — a net gain of 7 holders — while 3 added to existing stakes and 6 trimmed.

The largest buyer was Vanguard Group, adding an estimated $443K. The largest seller was Renaissance Technologies, cutting an estimated $54.2K.

  • 25 institutional investors held MiNK Therapeutics (INKT) as of Q4 2025, up from 18 in Q3 2025.
  • Funds reported $1.71M of MiNK Therapeutics stock for Q4 2025, up 34% quarter-over-quarter.
  • 7 funds opened new MiNK Therapeutics positions in Q4 2025 and 0 closed out, a net change of +7 holders.
  • The largest MiNK Therapeutics buyer in Q4 2025 was Vanguard Group, an estimated $443K added.
  • The largest MiNK Therapeutics seller in Q4 2025 was Renaissance Technologies, an estimated $54.2K sold.

Based on aggregated 13F filings for Q4 2025.